Inaktiver Wert

Termine ChemoCentryx, Inc.

Aktien

A0NBM2

US16383L1061

CCXI

Terminchart ChemoCentryx, Inc.

d2c31d.pVF76muWfYEZJ1sYZNT1scKwvWmfi58Pi3fy9FWNLbg._ylM3SPPRNBaUWMoKIvG-bDx8Tb-wtdCzASGjDa8Qon0Iz6sWtVJzitqYw~a8eaf6bba7f089901d512b9fddc534b6

Anstehende Termine für ChemoCentryx, Inc.

Es liegt kein Termin vor

Zurückliegende Termine für ChemoCentryx, Inc.

13.11.2022 16:15 American College of Rheumatology Convergence Conference - Abstract #1077
13.11.2022 16:10 American College of Rheumatology Convergence Conference - Abstract #1076
13.11.2022 15:00 American College of Rheumatology Convergence Conference - Abstract #1078
10.11.2022 21:15 American College of Rheumatology Convergence Conference - Abstract #525
10.11.2022 17:40 Society for Immunotherapy of Cancer Meeting - Abstract Number: 499
10.11.2022 17:40 Society for Immunotherapy of Cancer Meeting - Abstract Number: 769
05.11.2022 15:00 American Society of Nephrology Kidney Conference - Abstract #SA-PO696
05.11.2022 15:00 American Society of Nephrology Kidney Conference - Abstract #SA-PO633
04.11.2022 15:00 American Society of Nephrology Kidney Conference - Abstract #FR-PO651
18.10.2022 Ausserordentliche Aktionärsversammlung - M&A Vote
08.09.2022 Rheumatology Advanced Practice Providers National Conference
08.09.2022 Medscape LIVE! Perspectives in Rheumatic Diseases Conference
27.08.2022 07:30 European Meeting on Complement in Human Disease
09.08.2022 Erstes Halbjahr 2022 Ergebnisveröffentlichung Nachbörslich
22.06.2022 European Society for Pediatric Nephrology Conference
05.06.2022 15:00 American Society of Clinical Oncology Meeting - Abstract No 2593
02.06.2022 10:35 European Alliance of Associations for Rheumatology Conference - Oral Presentation No OP0180
01.06.2022 13:36 European Alliance of Associations for Rheumatology Conference - Poster No POS0835
01.06.2022 13:20 European Alliance of Associations for Rheumatology Conference - Poster No POS0833
26.05.2022 19:00 Jahreshauptversammlung
  1. Börse
  2. Aktien
  3. A0NBM2 Aktie
  4. Termine ChemoCentryx, Inc.